Article
Clinical Performance of Cas13a-based Point-of-Care Lateral Flow Assay for Detecting<i>Neisseria gonorrhoeae</i>
2024-03-04
Abstract excerpt
<h4>Background</h4> Diagnosis of Neisseria (N.) gonorrhoeae is dependent on nucleic acid amplification testing (NAAT), which is not available in resource-limited settings where the prevalence of infection is highest. Recent advances in molecular diagnostics leveraging the high specificity of CRISPR enzymes can permit field-deployable, point-of-care lateral flow assays. We previously reported on the development and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e4c8ea29-c3df-594e-99a2-f114af153344
- DOI
- 10.1101/2024.03.01.24303603
